Are you Dr. Bonnemann?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 28 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Children's Hospital Of Philadelphia - Neurology
Philadelphia, PA 19104Phone+1 215-590-1719Fax+1 215-590-1771
Summary
- Dr. Carsten Bonnemann, MD is a Child Neurologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania and District of Columbia. He is affiliated with Children's Hospital of Philadelphia.
Education & Training
Massachusetts General HospitalFellowship, Child Neurology, 1992 - 1995
Albert Ludwigs University Faculty of MedicineClass of 1989
Certifications & Licensure
DC State Medical License 2012 - 2024
PA State Medical License 2002 - 2024- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Genetic and Physical Study of Childhood Nerve and Muscle Disorders Start of enrollment: 2012 Mar 20
Publications & Presentations
PubMed
- 1 citationsAAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient.James J Dowling, Terry Pirovolakis, Keshini Devakandan, Ana Stosic, Mia Pidsadny
Nature Medicine. 2024-07-01 - 3 citationsPIEZO2-dependent rapid pain system in humans and mice.Otmane Bouchatta, Marek Brodzki, Houria Manouze, Gabriela B Carballo, Emma Kindström
Biorxiv. 2023-12-02 - 3 citations261st ENMC International Workshop: Management of safety issues arising following AAV gene therapy. 17th-19th June 2022, Hoofddorp, The Netherlands.Laurent Servais, Rebecca Horton, Dimah Saade, Carsten Bonnemann, Francesco Muntoni
Neuromuscular Disorders. 2023-11-01
Press Mentions
- Putting a Face on ResearchApril 12th, 2023
Gene That Makes Gentle Touch Feel Painful After Injury IdentifiedOctober 10th, 2018
Santhera’s Omigapil Found Safe and Well-Tolerated in Young CMD Patients in Phase 1 TrialApril 5th, 2018- Join now to see all
Grant Support
- Therapeutic Targets For The Congenital Muscular DystrophiesNational Institute Of Neurological Disorders And Stroke2009–2010
- The Molecular Basis Of Cmd Types Ullrich And BethlemNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2009
